Clinical trial
A Study to Evaluate the Performance, Usability, and Contrived Result Interpretation of TruPlex HIV/HepB/Syphilis Rapid Test by Trained Personnel at Near-Patient and Point-of-Care Settings
NCT07563309 is registered in ClinicalTrials.gov with bioLytical Laboratories as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Study to Evaluate the Performance, Usability, and Contrived Result Interpretation of TruPlex HIV/HepB/Syphilis Rapid Test by Trained Personnel at Near-Patient and Point-of-Care Settings
- Lead sponsor
- bioLytical Laboratories
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- December 18, 2025
- Completion date
- January 1, 2027
- Enrollment
- 1,000 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
hepatitis b infection, hiv 1 infection, hiv 2 infection, syphilis infection